RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells

European Journal of Cancer Care

Volumn 17, Issue 4, 2008, Pages 404-411

  Shen, S N ^a,b   Xu, Z ^a   Qian, X P ^b   Ding, Y T ^b   Yu, L X ^b   Liu, B R ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

B cell; CD40L; Hepatocellular carcinoma; Immunotherapy

Indexed keywords

CD40 ANTIGEN; MESSENGER RNA;

ADULT; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPHOCYTE ACTIVATION; MALE; METHODOLOGY;

ADULT; ANTIGENS, CD40; B-LYMPHOCYTES; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; RNA, MESSENGER;

EID: 48249096788     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2007.00841.x     Document Type: Article

References (38)

1. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F. Heath W.R. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478 480.
2. von Bergwelt-Baildon M.S., Vonderheide R.H., Maecker B., Hirano N., Anderson K.S., Butler M.O., Xia Z., Zeng W.Y., Wucherpfennig K.W., Nadler L.M. Schultze J.L. (2002) Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen- presenting cells: potential for clinical application. Blood 99, 3319 3325.
3. Bhatia S., Edidin M., Almo S.C. Nathenson S.G. (2005) Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proceedings of the National Academy of Sciences of the USA 102, 15569 15574.
4. Boon T. van der Bruggen P. (1996) Human tumor antigens recognized by T lymphocytes. Journal of Experimental Medicine 183, 725 729.
5. Bradbury L.E., Goldmacher V.S. Tedder T.F. (1993) The CD19 signal transduction complex of B lymphocytes: deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13. Journal of Immunology 151, 2915 2927.
6. Bubenik J., Otter W.D. Huland E. (2000) Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines. Cancer Immunology Immunotherapy 49, 116 122.
7. Collins A.V., Brodie D.W., Gilbert R.J., Iaboni A., Manso-Sancho R., Walse B., Stuart D.I., van der Merwe P.A. Davis S.J. (2002) The interaction properties of costimulatory molecules revisited. Immunity 17, 201 210.
8. Coughlin C.M., Vance B.A., Grupp S.A. Vonderheide R.H. (2004) RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy. Blood 103, 2046 2054.
9. Fearon D.T. Carter R.H. (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annual Review of Immunology 13, 127 149.
10. Grewal I.S. Flavell R.A. (1998) CD40 and CD154 in cell-mediated immunity. Annual Review of Immunology 16, 111 135.
11. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., Candeloro P., Belladonna M.L., Bianchi R., Fioretti M.C. Puccetti P. (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunology 3, 1097 1101.
12. Hirokawa M., Kuroki J., Kitabayashi A. Miura A.B. (1996) Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation. Immunology Letters 50, 95 98.
13. Ikeda H., Lethe B., Lehmann F., van Baren N., Baurain J.F., de Smet C., Chambost H., Vitale M., Moretta A., Boon T. Coulie P.G. (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6, 199 208.
14. Ikemizu S., Gilbert R.J., Fennelly J.A., Collins A.V., Harlos K., Jones E.Y., Stuart D.I. Davis S.J. (2000) Structure and dimerization of a soluble form of B7-1. Immunity 12, 51 60.
15. Kondo E., Topp M.S., Kiem H.P., Obata Y., Morishima Y., Kuzushima K., Tanimoto M., Harada M., Takahashi T. Akatsuka Y. (2002) Efficient generation of antigen specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. Journal of Immunology 169, 2164 2171.
16. Krop I., Shaffer A.L., Fearon D.T. Schlissel M.S. (1996) The signaling activity of murine CD19 is regulated during B cell development. Journal of Immunology 157, 48 56.
17. Lapointe R., Bellemare-Pelletier A., Housseau F., Thibodeau J. Hwu P. (2003) CD40-stimulated B lymphocytes pulsed with tumour antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Research 63, 2836 2843.
18. Llovet J.M., Burroughs A. Bruix J. (2003) Hepatocellular carcinoma. Lancet 362, 1907 1917.
19. Melero I., Mazzolini G., Narvaiza I., Qian C., Chen L. Prieto J. (2001) IL-12 gene therapy for cancer: in synergy with other immunotherapies. Trends in Immunology 22, 113 115.
20. Munn D.H., Sharma M.D. Mellor A.L. (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. Journal of Immunology 172, 4100 4110.
21. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G. Schadendorf D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Medicine 4, 269 270.
22. Okuda K. (2000) Hepatocellular carcinoma. Journal of Hepatology 32, 225 237.
23. Orabona C., Grohmann U., Belladonna M.L., Fallarino F., Vacca C., Bianchi R., Bozza S., Volpi C., Salomon B.L., Fioretti M.C., Romani L. Puccetti P. (2004) CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nature Immunology 5, 1134 1142.
24. Parkin D.M., Bray F., Ferlay J. Pisani P. (2001) Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 94, 153 156.
25. Ponsaerts P., Van Tendeloo V.F. Berneman Z.N. (2003) Cancer immunotherapy using RNA-loaded dendritic cells. Clinical and Experimental Immunology 134, 378 384.
26. Qian C., Drozdzik M., Caselmann W.H. Prieto J. (2000) Thepotential of gene therapy in the treatment of hepatocellular carcinoma. Journal of Hepatology 32, 344 351.
27. Ridge J.P., Di Rosa F. Matzinger P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4_ T-helper and a T-killer cell. Nature 393, 474 478.
28. Roy M., Waldschmidt T., Aruffo A., Ledbetter J.A. Noelle R.J. (1993) The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+T cells. Journal of Immunology 151, 2497 2510.
29. Sato S. (1999) CD19 is a central response regulator of B lymphocyte signaling thresholds governing autoimmunity. Journal of Dermatological Science 22, 1 10.
30. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R. Melief C.J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480 483.
31. Schultze J.L., Michalak S., Seamon M.J., Dranoff G., Jung K., Daley J., Delgado J.C., Gribben J.G. Nadler L.M. (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. Journal of Clinical Investigation 100, 2757 2765.
32. Suvas S., Singh V., Sahdev S., Vohra H. Agrewala J.N. (2002) Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. Journal of Biological Chemistry 277, 7766 7775.
33. Tedder T.F., Zhou L.J. Engel P. (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunology Today 15, 437 442.
34. Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P., Brocker E.B., Steinman R.M., Enk A., Kampgen E. Schuler G. (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. Journal of Experimental Medicine 190, 1669 1678.
35. Van den Bosch G.A., Ponsaerts P., Nijs G., Lenjou M., Vanham G., Van Bockstaele D.R., Berneman Z.N. Van Tendeloo V.F. (2005) Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells. Clinical and Experimental Immunology 139, 458 467.
36. Van Tendeloo V.F., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., Van Bockstaele D.R. Berneman Z.N. (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98, 49 56.
37. Zhang H.M., Zhang L.W., Ren J., Fan L., Si X.M. Liu W.C. (2006) Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T cell response using RNA-transfected dendritic cells. Cellular Immunology 239, 144 150.
38. Zhang X., Schwartz J.C., Almo S.C. Nathenson S.G. (2003) Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signalling. Proceedings of the National Academy of Sciences of the USA 100, 2586 2591.